Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arca Biopharma Inc (NQ: ABIO )

4.140 USD +0.020 (+0.49%)
Streaming Delayed Price Updated: 10:52 AM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 258,225
Open 4.184
Bid (Size) 4.110 (2)
Ask (Size) 4.150 (12)
Prev. Close 4.120
Today's Range 4.000 - 4.190
52wk Range 2.210 - 22.00
Shares Outstanding 13,923,825
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
From GlobeNewswire News Releases
Best Penny Stocks To Buy Right Now? 5 For Your January Watch List
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed

Performance

YTD
-0.48%
-0.48%
1 Month
-11.16%
-11.16%
3 Month
+1.22%
+1.22%
6 Month
-5.05%
-5.05%
1 Year
+22.12%
+22.12%

More News

Read More
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
From GlobeNewswire News Releases
Looking For Penny Stocks To Buy Now? 4 Biotech Stocks To Watch
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
From GlobeNewswire News Releases
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
From GlobeNewswire News Releases
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality
From GlobeNewswire News Releases
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19
From GlobeNewswire News Releases
ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19
From ACCESSWIRE
First Week of ABIO April 16th Options Trading
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.